EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Alzheimer’s Disease, Piezo2 Channelopathy, Piezo1 Channelopathy, and the Body-Wide Piezo2 System

Balazs Sonkodi

Frontiers in Bioscience-Landmark · 2026

DOI: 10.31083/fbl52555 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, 2026. Verfasst von Balazs Sonkodi. Beteiligte Einrichtung: Department of Health Sciences and Sport Medicine, Hungarian University of Sports Science, 1123 Budapest, Hungary. Hauptthemen laut MEDLINE: Alzheimer Disease, Ion Channels, Channelopathies. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hungarian University of Sports Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease initiates pathophysiology in the 10 to 20 years prior to detectable clinical symptoms. A recent genetic analysis implicated the critical role of Piezo2 in Alzheimer’s disease pathophysiology. A recent genetic study, involving PIEZO1 manipulation, showed that phosphatidylinositol 4,5-bisphosphate (PIP2) rectified brain capillary endothelial Piezo1 channelopathy in a mouse model of Alzheimer’s disease. However, the present opinion paper posits that the initiating microdamage is in the prefrontal cortex, further upstream of pathophysiology, namely an irreversible Piezo2 channelopathy of glutamatergic terminals that is proposed to finely regulate oxytocin release resulting from stressful ultradian events, leading to impaired ultradian rhythm. The involvement of Piezo2 in the defensive arousal response reveals an underlying body-wide Piezo2 system of which the proposed prefrontal Piezo2 channelopathy is possibly a critical locus. PIP2 is emerging as a potential treatment method for Piezo channelopathy in Alzheimer’s disease. However, the challenge of its more precise administration to target affected regions of the brain still remains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseIon ChannelsChannelopathiesHumansAnimalsMicePhosphatidylinositol 4,5-Diphosphate

Stichwörter der Autor:innen

Alzheimer diseasePiezo1Piezo2channelopathyoxytocinultradian rhythm

Substanzen

Ion ChannelsPIEZO2 protein, humanPIEZO1 protein, humanPhosphatidylinositol 4,5-Diphosphate

Autor:innen und Institutionen

  • Department of Health Sciences and Sport Medicine, Hungarian University of Sports Science, 1123 Budapest, Hungary.
  • Department of Sports Medicine, Semmelweis University, 1122 Budapest, Hungary.
  • Faculty of Health Sciences, Institute of Physiotherapy and Sport Science, University of Pécs, 7624 Pécs, Hungary.
  • Physical Activity Research Group, Szentágothai Research Centre, University of Pécs, 7624 Pécs, Hungary.

Förderung

  • Hungarian University of Sports Science

Zitieren

APA

Sonkodi, B. (2026). Alzheimer’s Disease, Piezo2 Channelopathy, Piezo1 Channelopathy, and the Body-Wide Piezo2 System. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl52555

Vancouver

Sonkodi B. Alzheimer’s Disease, Piezo2 Channelopathy, Piezo1 Channelopathy, and the Body-Wide Piezo2 System. Frontiers in Bioscience-Landmark. 2026. doi:10.31083/fbl52555

BibTeX
@article{Sonkodi2026,
  author = {Sonkodi, Balazs},
  title = {Alzheimer’s Disease, Piezo2 Channelopathy, Piezo1 Channelopathy, and the Body-Wide Piezo2 System},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  doi = {10.31083/fbl52555}
}
Kostenlos starten →